10h agoOpenAI updates GPT-Rosalind, integrating GPT-5.5's agentic tool use and coding for specialized drug discovery and molecular designG1 top authorThe upgrade targets professional scientific research at enterprise scale.Original postGRGreg Brockman@gdbMajor upgrade to GPT-Rosalind, with much better intelligence for drug discovery, analysis, design, and experimental workflows:2:56 PM · Jun 3, 2026SentimentSentimentPos68%Neg32%Many users praised GPT-Rosalind's potential to accelerate drug discovery and life sciences, while others voiced frustration over OpenAI removing access to GPT-4o.72 comments with sentiment. View comments.
